Evaluating the Feasibility and Safety of Daily Inter-facility Travel for Proton Beam Therapy During Chemotherapy-Induced Myelosuppression in Children With Cancer
In this cohort, daily inter-facility travel for pediatric PBT during chemotherapy-induced myelosuppression was feasible. Although brief treatment interruptions were more frequent in the PBT group, infectious outcomes were comparable to those of patients receiving XRT without transfer, and no travel- or sedation-related adverse events were identified. Coordinated multidisciplinary protocols may help minimize avoidable interruptions while maintaining safety.
Authors
- Eri Okura
- Yu Furui (ORCID: https://orcid.org/0000-0002-8171-4907)
- Masayuki Araya (ORCID: https://orcid.org/0000-0002-8529-5420)
- Hirokazu Morokawa
- Eriko Uchida
- Takashi Kurata (ORCID: https://orcid.org/0000-0001-6195-9854)
- Shoji Saito (ORCID: https://orcid.org/0000-0003-3866-3582)
- Keiichiro Koiwai (ORCID: https://orcid.org/0000-0002-3582-7572)
- Yozo Nakazawa
- Koichi Hirabayashi
- Kazutoshi Komori
- Naoto Mizushiro
- Daisuke Morita
- Hidekazu Masaki
- Miyuki Tanaka
Institutions
- Shinshu University (JP)
- Shinshu University Hospital (JP)
- Nagano Children's Hospital (JP)
- Aizawa Hospital (JP)
Publication Details
- Journal
- Cureus
- Published
- 2026-02-05
- DOI
- https://doi.org/10.7759/cureus.103052
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00